It has been suggested that elevated levels of PPARα in diabetic hearts contribute to the development of metabolic and functional alterations that characterize diabetic cardiomyopathy by promoting cardiac steatosis and lipotoxicity through the activation of the expression of genes related to fatty acid uptake and oxidation. The gene discussed is PPARA; the disease is diabetic cardiomyopathy.